Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ajsn6c
    Junior Member
    • Oct 2015
    • 7

    #1

    ChIP-seq and Peak calling

    I have a simple question that I would like some opinions on. If a transcription factor is highly expressed (protein) in one cell and say now that the expression of is halved because of knock down experiment and you do ChIP-seq on both conditions, would you expect a similar amount peaks found using MACS, or rather a lower level of signal intensity in the knock down condition. I would think just a lower signal, but I'm curious what you all think

    Thanks!
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    My guess is that some peaks would be largely unaffected while others would vanish completely. This is mostly because I would guess that in some regions the factor would be more heavily recruited and/or bind with higher affinity, thereby sponging up the available supply. Of course, one could also envisage a scenario wherein signal intensity is roughly halved globally (of course, scaling might screw this up), or decreased even further (e.g., if binding can only occur as dimers and the probability of dimerization is now lower).

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    24 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...